PWC News
Saturday, May 16, 2026
No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis
No Result
View All Result
PWC News
No Result
View All Result

AstraZeneca considers moving listing to US, the Times reports

Home Business
Share on FacebookShare on Twitter


(Reuters) -AstraZeneca is contemplating transferring its inventory market itemizing from London, the place it’s the trade’s most respected firm, to america, the Instances reported on Tuesday, citing a number of sources.

Any such transfer could be a significant blow to the UK inventory market, which has seen a string of delistings and missed out on some main preliminary public choices in latest months.

It will additionally attraction to President Donald Trump’s hopes of drawing funding to america, whilst his commerce coverage has created uncertainty for international firms. He has threatened to impose 25% tariffs on pharmaceutical imports.

CEO Pascal Soriot has privately expressed a desire to shift AstraZeneca’s itemizing on a number of events and has additionally mentioned relocating the corporate’s domicile, the Instances mentioned.

AstraZeneca, which has a market worth of about 156 billion kilos ($213 billion), declined to remark.

The corporate has for years criticised the UK enterprise funding local weather. In January it scrapped plans to speculate 450 million kilos in its vaccine manufacturing plant in northern England, citing a lower in authorities assist.

In the meantime, the corporate has been strengthening its ties to the U.S. over the previous 12 months, each when it comes to manufacturing funding and contacts with buyers and lawmakers.

Its U.S. plans embody a $3.5 billion funding in home manufacturing by the tip of 2026. The corporate earlier this 12 months additionally rejoined the main U.S. drug foyer group, roughly two years after leaving it.

The U.S. can be AstraZeneca’s largest market, accounting for about 42% of its income within the first quarter of this 12 months.

Soriot may face opposition from some board members and the UK authorities if he pursues the transfer, in keeping with the Instances report, which added that the federal government had not been knowledgeable.

London-listed shares in AstraZeneca final traded up 2.8% at 10,328 pence.

(Reporting by Mrinalika Roy, Aatrayee Chatterjee and Shanima A in Bengaluru, Patrick Wingrove in New York, and Maggie Fick in London; Enhancing by Leroy Leo and Mark Potter)



Source link

Tags: AstraZenecaConsidersListingmovingreportsTimes
Previous Post

The 3 ESG Blind Spots That Could Cost You a Deal in 2025

Next Post

Airlines want retroactive exemption on compensation claims

Related Posts

How Trump’s ‘unusual’ brokerage account traded around his own market-moving decisions—selling hyperscalers and buying energy stocks during the war | Fortune
Business

How Trump’s ‘unusual’ brokerage account traded around his own market-moving decisions—selling hyperscalers and buying energy stocks during the war | Fortune

May 16, 2026
China-U.S. Relations: What To Expect From ‘Constructive Strategic Stability’?
Business

China-U.S. Relations: What To Expect From ‘Constructive Strategic Stability’?

May 15, 2026
Mass Exodus: Young Residents Fleeing Greater Boston
Business

Mass Exodus: Young Residents Fleeing Greater Boston

May 16, 2026
Israels Consumer Price Index jumped in April
Business

Israels Consumer Price Index jumped in April

May 15, 2026
Monsoon to hit Kerala coast on May 26: IMD
Business

Monsoon to hit Kerala coast on May 26: IMD

May 15, 2026
US stocks today: US stocks end higher on tech rally; investors eye Beijing talks
Business

US stocks today: US stocks end higher on tech rally; investors eye Beijing talks

May 14, 2026
Next Post
Airlines want retroactive exemption on compensation claims

Airlines want retroactive exemption on compensation claims

Cliff Asness’ AQR sees multiple hedge funds up double digits in 2025, beating the market

Cliff Asness’ AQR sees multiple hedge funds up double digits in 2025, beating the market

Vodafone Idea AGR Dues: No Relief Planned At The Moment, Says Union MoS

Vodafone Idea AGR Dues: No Relief Planned At The Moment, Says Union MoS

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Biggest Change To Trading In 25 Years
Markets

Biggest Change To Trading In 25 Years

by PWC
May 14, 2026
0

It’s the tip of an period. For these of you who don’t know… The Sample Day Dealer (PDT) Rule limits...

Is the Sustainability world in freefall?

Is the Sustainability world in freefall?

May 16, 2026
Conversations with Frank Fabozzi, CFA, Featuring Sue Brake

Conversations with Frank Fabozzi, CFA, Featuring Sue Brake

May 11, 2026
Cameron Hamilton, fired by Trump for defending FEMA’s right to exist, tapped to lead FEMA by Trump | Fortune

Cameron Hamilton, fired by Trump for defending FEMA’s right to exist, tapped to lead FEMA by Trump | Fortune

May 12, 2026
Top Wall Street analysts recommend these 3 dividend stocks for stable income

Top Wall Street analysts recommend these 3 dividend stocks for stable income

May 10, 2026
US Credit Card Debt Hits Record .33 Trillion as Savings Rate Crumbles

US Credit Card Debt Hits Record $1.33 Trillion as Savings Rate Crumbles

May 9, 2026
PWC News

Copyright © 2024 PWC.

Your Trusted Source for ESG, Corporate, and Financial Insights

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact Us

Follow Us

No Result
View All Result
  • Home
  • Business
  • Economy
  • ESG Business
  • Markets
  • Investing
  • Energy
  • Cryptocurrency
  • Market Analysis

Copyright © 2024 PWC.